Arrowstreet Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.18M | Buy |
+6,063
| New | +$3.18M | ﹤0.01% | 1314 |
|
|
2023
Q4 | – | Sell |
-2,262
| Closed | -$1.86M | – | 1536 |
|
|
2023
Q3 | $1.86M | Hold |
2,262
| – | – | ﹤0.01% | 873 |
|
|
2023
Q2 | $1.63M | Buy |
+2,262
| New | +$1.63M | ﹤0.01% | 883 |
|
|
2023
Q1 | – | Sell |
-1,661
| Closed | -$1.2M | – | 1488 |
|
|
2022
Q4 | $1.2M | Buy |
1,661
+656
| +65% | +$473K | ﹤0.01% | 987 |
|
|
2022
Q3 | $692K | Sell |
1,005
-177,537
| -99% | -$122M | ﹤0.01% | 1052 |
|
|
2022
Q2 | $106M | Buy |
178,542
+142,319
| +393% | +$84.1M | 0.15% | 147 |
|
|
2022
Q1 | $25.3M | Buy |
36,223
+31,609
| +685% | +$22.1M | 0.03% | 366 |
|
|
2021
Q4 | $2.91M | Buy |
+4,614
| New | +$2.91M | ﹤0.01% | 938 |
|
|
2021
Q1 | – | Sell |
-700
| Closed | -$338K | – | 2479 |
|
|
2020
Q4 | $338K | Sell |
700
-11,500
| -94% | -$5.55M | ﹤0.01% | 2098 |
|
|
2020
Q3 | $6.83M | Buy |
+12,200
| New | +$6.83M | 0.01% | 1005 |
|
|
2019
Q3 | – | Sell |
-403,526
| Closed | -$126M | – | 1684 |
|
|
2019
Q2 | $126M | Buy |
403,526
+93,195
| +30% | +$29.2M | 0.28% | 87 |
|
|
2019
Q1 | $127M | Buy |
310,331
+233,356
| +303% | +$95.8M | 0.3% | 62 |
|
|
2018
Q4 | $28.8M | Buy |
+76,975
| New | +$28.8M | 0.08% | 245 |
|
|
2018
Q1 | – | Sell |
-1,000
| Closed | -$376K | – | 1301 |
|
|
2017
Q4 | $376K | Buy |
+1,000
| New | +$376K | ﹤0.01% | 1106 |
|
|
2015
Q4 | – | Sell |
-40,069
| Closed | -$18.6M | – | 1567 |
|
|
2015
Q3 | $18.6M | Sell |
40,069
-31,336
| -44% | -$14.6M | 0.09% | 219 |
|
|
2015
Q2 | $36.4M | Buy |
+71,405
| New | +$36.4M | 0.21% | 119 |
|
|
2014
Q1 | – | Sell |
-31,466
| Closed | -$8.66M | – | 1303 |
|
|
2013
Q4 | $8.66M | Buy |
+31,466
| New | +$8.66M | 0.05% | 318 |
|